Critics also note that no women were allowed to participate in final
negotiations over the measure, which were conducted by Cuomo and top lawmakers, all men.
Not exact matches
In the most recent bout of
negotiations over the weekend, the deal reportedly sputtered out
over the number of unauthorized immigrants covered under the deal, and certain immigration enforcement - related
measures that Republicans wanted to include but Democrats considered nonstarters.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity
measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future
negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products
over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
On a more fundamental level, the
negotiations remain at an impasse
over a collection of U.S. proposals dubbed «poison pills» by U.S. Chamber President and CEO Thomas J. Donohue, including the proposed sunset clause, an extreme approach to rule of origins for the auto and textile / apparel sectors, and
measures that would undermine investment protection, government procurement, and trade in seasonal produce.
The U.S. government called off
negotiations with Brazil on tariffs
over U.S. protectionist
measures and reinstated tariffs and quotas on imports of Brazilian steel and aluminum, according to a statement by the Brazilian government on Wednesday.
The
measure has universal support across the Adirondack Park, including environmental advocacy organizations, state and local officials and business groups — all of whom helped forge the agreement
over years of painstaking
negotiations.
One of the delicate
negotiations currently under way is likely
over whether supporters can find more than one additional vote for the
measure, and to whom those votes might belong.
But civic groups fought against the
measure, arguing instead for a long - term permit that might nudge
negotiations over relocating the arena so that Penn Station might be rebuilt and expanded.
Lawmakers at this point have taken the unusual step of not introducing Cuomo's ethics
measures as a way of preserving some leverage
over the governor during the
negotiations.
ALBANY — Even as
negotiations over rent regulations, the 421 - a housing program, and other issues remain unresolved, the State Senate on Wednesday passed a
measure that would designate the wood frog as the official state amphibian.
Cuomo said he will push, as part of the budget
negotiations over the next two weeks,
measures to take guns away from all convicted domestic violence offenders and expand the background check waiting period to 10 days.
Negotiations over rules for
measuring emissions and schemes for trading greenhouse gas credits take diplomats deep into difficult details.
Those
negotiations eventually stalled
over disagreements on verification
measures and inspections, which were unresolved when the Bush administration left office.
Although ICAO's 192 member states had long agreed to technology, operations and infrastructure
measures to help address GHG emissions from international aviation,
negotiations over a market - based
measure (MBM) stalled for several years, leading to efforts by multiple countries to implement their own regulations or taxes on international aviation emissions.
Irrespective of how these issues are ultimately resolved, it is clear that the
negotiations over the withdrawal agreement (and potentially any transitional
measures and future trade deal) are now likely to require substantial work on institutional arrangements to account for the settlement of potential disputes arising after the UK has formally left the EU, in addition to the more mainstream issues of assets, liabilities, citizens» rights, pensions etc..
transparent and accountable frameworks for engagement, consultation and
negotiation with indigenous peoples and communities, which could include specific, time - bound and verifiable benchmarks and indicators to ensure that progress can be tracked and
measured over time;